低分子肝素钙联合法舒地尔治疗后循环缺血63例疗效探讨

Low Molecular Heparin Calcium Combined Method of Shu Ground Treatment Clinical Observation on 63 Cases of Posterior Circulation Ischemia

目的探讨分低分子肝素钙联合法舒地尔治疗后循环缺血的临床疗效。方法整群选择该院2012年1月—2014年1月收治的63例后循环缺血患者为研究对象,并按治疗方法的不同将其分为治疗组33例,对照组30例。给予治疗组低分子肝素钙联合法舒地尔治疗,给予对照组常规治疗,对比两组治疗结果。结果两组治疗后PT、INR、APTT、Fb、PLT水平比较差异不显著,且两组治疗过程中均未出现不良反应。然而,治疗组治疗总有效率为93.94%;对照组为73.33%;治疗组明显大于对照组,两组比较差异具有统计学意义,P<0.05。结论相比于常规治疗手段,联合应用低分子肝素钙以及法舒地尔治疗后循环缺血的效果明显,治疗痊愈率高,不良反应少,因此该治疗方法值得临床推广应用。

Objective To study the points of low molecular heparin calcium combined method of shu, clinical curative effect for the treatment of posterior circulation ischemia. Methods 63 cases of patients with posterior circulation ischemia in our hospital as the research object, and follow the different treatments will be divided into the treatment group（33 cases, control group 30 cases.Treated group and low molecular heparin calcium combined method of shu ground treatment, give control group routine treatment,compared two groups of treatment results. Results Two groups after treatment, INR, APTT and PT Fb, PLT level comparative difference was not significant, and no adverse reactions occurred in the process of treatment of the two groups. However, treatment group total effective rate was 93.94%; The control group is 73.33%; Treatment group was significantly greater than the control group, two groups compare differences statistically significant,（P〈0.05）. Conclusion Compared with the conventional treatment,combined use of low molecular heparin calcium and shu, the effect of the treatment of posterior circulation ischemia, treatment of high cure rate, less adverse reaction, so the treatment is worthy of clinical application.